Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy

Malignant melanoma is one kind of malignant disease which has high rates of mortality, metastasis, and poor prognosis. The therapeutic landscape is rapidly changing with the development of novel agents in recent decades, such as anti-PD-1 agents, anti-CTLA-4 agents, and BRAF inhibitors. However, sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Cong, Shen, Jiayu, Ying, Jieer, Fang, Xianhua, Wang, Xiaohong, Fu, Zhixuan, Liu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604556/
https://www.ncbi.nlm.nih.gov/pubmed/29066909
http://dx.doi.org/10.2147/OTT.S146409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604556/
https://www.ncbi.nlm.nih.gov/pubmed/29066909
http://dx.doi.org/10.2147/OTT.S146409

Ejemplares similares